Another study showed that knockdown of the three prime repair exonuclease 1 (TREX1) enhanced stemmness properties and resistance to cisplatin and doxorubicin in osteosarcoma cells through the E2F4-mediated activation of the Wnt/β-catenin pathway [70]. The gene discussed is TREX1; the disease is osteosarcoma.